Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia A Kuijpers

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular Membrane Biology|October 14, 2010
Liposomes targeting tumour stromal cellsSylvia A Kuijpers, Maria J Coimbra, Gert Storm, et al.
Current Pharmaceutical Design|June 13, 2009
Targeted delivery of anti-inflammatory agents to tumorsMaria Coimbra, Sylvia A Kuijpers, Sebastiaan P van Seters, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma modelAnil K Deshantri, Sander A A Kooijmans, Sylvia A Kuijpers, et al.
Oncotarget|June 17, 2014
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammationTom Groot Kormelink, Desmond G Powe, Sylvia A Kuijpers, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular Membrane Biology|October 14, 2010
Liposomes targeting tumour stromal cellsSylvia A Kuijpers, Maria J Coimbra, Gert Storm, et al.
Current Pharmaceutical Design|June 13, 2009
Targeted delivery of anti-inflammatory agents to tumorsMaria Coimbra, Sylvia A Kuijpers, Sebastiaan P van Seters, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2016
Liposomal prednisolone inhibits tumor growth in a spontaneous mouse mammary carcinoma modelAnil K Deshantri, Sander A A Kooijmans, Sylvia A Kuijpers, et al.
Oncotarget|June 17, 2014
Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammationTom Groot Kormelink, Desmond G Powe, Sylvia A Kuijpers, et al.
Pageof 1